Use of cellular biotechnologies in treatment metastatic pericarditis at patients with tumors of female reproductive system
Malignant pericardial effusions often arise in patients with breаst cancer and ovarian cancer. Sistem antitumor therapy is uneffective in gen- erally and causes side effects. Here we show that intrapericardial interleukin-2 with allogenеc lymphokine-activated killers and interleukin-2 immunotherapy...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/66 |
| _version_ | 1826557358070824960 |
|---|---|
| author | K. S. Titov S. M. Volkov L. V. Demidov A. N. Gritsay N. I. Lazareva M. V. Kiselevskiy A. P. Nikolayev |
| author_facet | K. S. Titov S. M. Volkov L. V. Demidov A. N. Gritsay N. I. Lazareva M. V. Kiselevskiy A. P. Nikolayev |
| author_sort | K. S. Titov |
| collection | DOAJ |
| description | Malignant pericardial effusions often arise in patients with breаst cancer and ovarian cancer. Sistem antitumor therapy is uneffective in gen- erally and causes side effects. Here we show that intrapericardial interleukin-2 with allogenеc lymphokine-activated killers and interleukin-2 immunotherapy demonstrated the high efficacy in threatment of breаst and ovarian cancer patients with malignant pericardial effusions. The objective effect was 92.3 % аnd 90.0 % accordingly. These results indicates that intrapericardial immunotherapy might be one of the stages of combined treatment of such group of patients. The suggested type of biotherapy increases the survival and life quality of patients. |
| first_indexed | 2024-04-10T01:57:52Z |
| format | Article |
| id | doaj.art-acbcba1d10864a0f941029fe597951e7 |
| institution | Directory Open Access Journal |
| issn | 1994-4098 1999-8627 |
| language | Russian |
| last_indexed | 2025-03-14T08:27:19Z |
| publishDate | 2014-07-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Опухоли женской репродуктивной системы |
| spelling | doaj.art-acbcba1d10864a0f941029fe597951e72025-03-02T13:05:28ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-07-0103-410110410.17650/1994-4098-2013-0-3-4-101-10481Use of cellular biotechnologies in treatment metastatic pericarditis at patients with tumors of female reproductive systemK. S. Titov0S. M. Volkov1L. V. Demidov2A. N. Gritsay3N. I. Lazareva4M. V. Kiselevskiy5A. P. Nikolayev6N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowMalignant pericardial effusions often arise in patients with breаst cancer and ovarian cancer. Sistem antitumor therapy is uneffective in gen- erally and causes side effects. Here we show that intrapericardial interleukin-2 with allogenеc lymphokine-activated killers and interleukin-2 immunotherapy demonstrated the high efficacy in threatment of breаst and ovarian cancer patients with malignant pericardial effusions. The objective effect was 92.3 % аnd 90.0 % accordingly. These results indicates that intrapericardial immunotherapy might be one of the stages of combined treatment of such group of patients. The suggested type of biotherapy increases the survival and life quality of patients.https://ojrs.abvpress.ru/ojrs/article/view/66malignant pericardial effusionsbreаst cancerovarian cancerinterleukin-2allogenec lymphokine-activated killersintraperi- cardial immunotherapy |
| spellingShingle | K. S. Titov S. M. Volkov L. V. Demidov A. N. Gritsay N. I. Lazareva M. V. Kiselevskiy A. P. Nikolayev Use of cellular biotechnologies in treatment metastatic pericarditis at patients with tumors of female reproductive system Опухоли женской репродуктивной системы malignant pericardial effusions breаst cancer ovarian cancer interleukin-2 allogenec lymphokine-activated killers intraperi- cardial immunotherapy |
| title | Use of cellular biotechnologies in treatment metastatic pericarditis at patients with tumors of female reproductive system |
| title_full | Use of cellular biotechnologies in treatment metastatic pericarditis at patients with tumors of female reproductive system |
| title_fullStr | Use of cellular biotechnologies in treatment metastatic pericarditis at patients with tumors of female reproductive system |
| title_full_unstemmed | Use of cellular biotechnologies in treatment metastatic pericarditis at patients with tumors of female reproductive system |
| title_short | Use of cellular biotechnologies in treatment metastatic pericarditis at patients with tumors of female reproductive system |
| title_sort | use of cellular biotechnologies in treatment metastatic pericarditis at patients with tumors of female reproductive system |
| topic | malignant pericardial effusions breаst cancer ovarian cancer interleukin-2 allogenec lymphokine-activated killers intraperi- cardial immunotherapy |
| url | https://ojrs.abvpress.ru/ojrs/article/view/66 |
| work_keys_str_mv | AT kstitov useofcellularbiotechnologiesintreatmentmetastaticpericarditisatpatientswithtumorsoffemalereproductivesystem AT smvolkov useofcellularbiotechnologiesintreatmentmetastaticpericarditisatpatientswithtumorsoffemalereproductivesystem AT lvdemidov useofcellularbiotechnologiesintreatmentmetastaticpericarditisatpatientswithtumorsoffemalereproductivesystem AT angritsay useofcellularbiotechnologiesintreatmentmetastaticpericarditisatpatientswithtumorsoffemalereproductivesystem AT nilazareva useofcellularbiotechnologiesintreatmentmetastaticpericarditisatpatientswithtumorsoffemalereproductivesystem AT mvkiselevskiy useofcellularbiotechnologiesintreatmentmetastaticpericarditisatpatientswithtumorsoffemalereproductivesystem AT apnikolayev useofcellularbiotechnologiesintreatmentmetastaticpericarditisatpatientswithtumorsoffemalereproductivesystem |